Pharmaron Beijing Statistics
Total Valuation
HKG:3759 has a market cap or net worth of HKD 47.33 billion. The enterprise value is 51.09 billion.
Market Cap | 47.33B |
Enterprise Value | 51.09B |
Important Dates
The last earnings date was Thursday, March 27, 2025.
Earnings Date | Mar 27, 2025 |
Ex-Dividend Date | Jun 27, 2024 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | -0.11% |
Shares Change (QoQ) | +0.32% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 1.21B |
Valuation Ratios
The trailing PE ratio is 24.80.
PE Ratio | 24.80 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | 4.42 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.31, with an EV/FCF ratio of 89.57.
EV / Earnings | 26.77 |
EV / Sales | 3.88 |
EV / EBITDA | 17.31 |
EV / EBIT | 27.72 |
EV / FCF | 89.57 |
Financial Position
The company has a current ratio of 1.80, with a Debt / Equity ratio of 0.42.
Current Ratio | 1.80 |
Quick Ratio | 1.44 |
Debt / Equity | 0.42 |
Debt / EBITDA | 2.17 |
Debt / FCF | 11.15 |
Interest Coverage | 7.05 |
Financial Efficiency
Return on equity (ROE) is 12.48% and return on invested capital (ROIC) is 4.98%.
Return on Equity (ROE) | 12.48% |
Return on Assets (ROA) | 4.26% |
Return on Invested Capital (ROIC) | 4.98% |
Return on Capital Employed (ROCE) | 8.73% |
Revenue Per Employee | 611,303 |
Profits Per Employee | 89,304 |
Employee Count | 21,370 |
Asset Turnover | 0.49 |
Inventory Turnover | 7.60 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +67.22% in the last 52 weeks. The beta is 0.89, so HKG:3759's price volatility has been lower than the market average.
Beta (5Y) | 0.89 |
52-Week Price Change | +67.22% |
50-Day Moving Average | 15.70 |
200-Day Moving Average | 12.84 |
Relative Strength Index (RSI) | 48.50 |
Average Volume (20 Days) | 7,626,711 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:3759 had revenue of HKD 13.06 billion and earned 1.91 billion in profits. Earnings per share was 1.08.
Revenue | 13.06B |
Gross Profit | 4.45B |
Operating Income | 1.83B |
Pretax Income | 2.23B |
Net Income | 1.91B |
EBITDA | 2.75B |
EBIT | 1.83B |
Earnings Per Share (EPS) | 1.08 |
Balance Sheet
The company has 3.26 billion in cash and 6.36 billion in debt, giving a net cash position of -3.09 billion.
Cash & Cash Equivalents | 3.26B |
Total Debt | 6.36B |
Net Cash | -3.09B |
Net Cash Per Share | n/a |
Equity (Book Value) | 15.14B |
Book Value Per Share | 8.21 |
Working Capital | 3.60B |
Cash Flow
In the last 12 months, operating cash flow was 2.74 billion and capital expenditures -2.17 billion, giving a free cash flow of 570.41 million.
Operating Cash Flow | 2.74B |
Capital Expenditures | -2.17B |
Free Cash Flow | 570.41M |
FCF Per Share | n/a |
Margins
Gross margin is 34.09%, with operating and profit margins of 14.01% and 14.61%.
Gross Margin | 34.09% |
Operating Margin | 14.01% |
Pretax Margin | 17.04% |
Profit Margin | 14.61% |
EBITDA Margin | 21.04% |
EBIT Margin | 14.01% |
FCF Margin | 4.37% |
Dividends & Yields
This stock pays an annual dividend of 0.22, which amounts to a dividend yield of 1.37%.
Dividend Per Share | 0.22 |
Dividend Yield | 1.37% |
Dividend Growth (YoY) | -33.08% |
Years of Dividend Growth | n/a |
Payout Ratio | 30.24% |
Buyback Yield | 0.11% |
Shareholder Yield | 1.48% |
Earnings Yield | 4.03% |
FCF Yield | 1.21% |
Stock Splits
The last stock split was on July 18, 2023. It was a forward split with a ratio of 1.5.
Last Split Date | Jul 18, 2023 |
Split Type | Forward |
Split Ratio | 1.5 |
Scores
HKG:3759 has an Altman Z-Score of 3.66.
Altman Z-Score | 3.66 |
Piotroski F-Score | n/a |